Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
USE CASES
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
PatSnap Eureka Desktop
NEWAnalytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
NEWServices professionnels
Cabinets d'avocats
Sciences de la vie
Haute technologie
Competitor Tech Research
Design Risk Screening
Telecom SEP Claim Chart
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport How engineers use failure tree analysis to prioritize reliability improvement investments in complex electromechanical systems — methodology, tools, and decision frameworks.
Article | Rapport How AI is transforming the way engineering teams capture, structure, and reuse institutional knowledge across product generations — key strategies and tools.
Article | Rapport How engineers build supply chain resilience for critical rare earth materials in advanced manufacturing — strategies, frameworks, and patent intelligence.
Article | Rapport Researching ultrasonic vs laser welding for medical device assembly? Learn which patent databases and search strategies surface the best engineering intelligence.
Article | Rapport Learn the key differences between forward and backward citation analysis in patent landscape research — and how each technique powers smarter IP strategy.
Article | Rapport Why is carbon fiber still too expensive for mass-market cars? Explore the key technical barriers in precursor chemistry, processing, and cycle time — with patent intelligence.
Article | Rapport Understand the key differences between open-loop and closed-loop process control in high-precision semiconductor manufacturing equipment — explained for process engineers.
Article | Rapport Explore the key engineering challenges of next-generation haptic feedback systems for surgical robotics — from force sensing to latency and miniaturisation.
Article | Rapport Explore how incremental and breakthrough innovation differ in materials science for industrial applications — and how patent intelligence reveals each strategy.
Article | Rapport Explore the 2026 biodegradable implant materials landscape: magnesium alloys, PLGA polymers, and silk fibroin scaffolds across orthopedic and cardiovascular R&D.
Article | Rapport Explore the MOF materials landscape for gas separation and drug delivery in 2026. Patent trends, key applications, and innovation intelligence from PatSnap.
Article | Rapport Fluorescent, phosphorescent, and TADF emitter materials compared: efficiency ceilings, key molecular architectures, IP trends, and what R&D teams need to know in 2026.
Article | Rapport Explore the 2026 flexible substrate materials landscape for wearable electronics and e-skin: key material approaches, innovation signals, and how to build a credible IP analysis.
Article | Rapport Explore the 2026 catalyst materials landscape for green hydrogen PEM and alkaline electrolyzers: iridium oxide, nickel-iron, PGM alternatives, and patent trends.
Article | Rapport Pfizer and Arvinas are advancing vepdegestrant, the first PROTAC ER degrader, toward FDA submission for ESR1-mutant breast cancer. Here's what the IP landscape reveals.